Dr. Vithalani completed medical school at King's College London, United Kingdom. She completed her family medicine residency at the Penn State Health Family Medicine Residency Program at Mount Nittany Medical Center where she served as chief resident. She was honored with the American Academy of Family Physicians Leadership in Graduate Medical Education award and is board certified by the American Board of Family Medicine.
Prior to joining Geisinger, Dr. Vithalani worked for the National Health Service at Addenbrooke’s Hospital in Cambridge, United Kingdom. She returned to America and pursued fellowship training in one of the country's leading palliative care programs at Kaiser Permanente Los Angeles Medical Center in California.
She is a professional member of the American Academy of Hospice and Palliative Medicine and the American Academy of Family Physicians.
Palliative care can be provided alongside treatments with curative intentions, as well as focus on symptoms that may occur as part of these illnesses or treatments. Dr Vithalani will be available for inpatient consultations at Geisinger Lewistown Hospital, as well as outpatient clinic at in the Community Cancer Treatment Center at 211 3rd Street, Lewistown PA 17044. To consult with Dr. Vithalani, ask your doctor to place a referral for Palliative Medicine Outpatient and have their office call 717-242-7297 to schedule an appointment. For patients outside the Geisinger system, your doctor’s office may call 717-242-7297 to schedule an appointment.
Geisinger is committed to making better health easier for the more than 1.5 million consumers it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 13 hospital campuses, a 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. With 32,000 employees and 1,800 employed physicians, Geisinger boosts its hometown economies in Pennsylvania and New Jersey by billions of dollars annually. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.